{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:12Z","timestamp":1786987512751,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":134,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.crphar.2024.100183","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T04:06:22Z","timestamp":1715832382000},"page":"100183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Stem cell therapy as a promising approach for ischemic stroke treatment"],"prefix":"10.1016","volume":"6","author":[{"given":"Sahar","family":"Yaqubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-8902","authenticated-orcid":false,"given":"Mohammad","family":"Karimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.crphar.2024.100183_bib1","article-title":"Unlocking the mysteries, bridging the gap, and unveiling the multifaceted potential of stem cell therapy for cardiac tissue regeneration: a narrative review of current literature, ethical challenges, and future perspectives","volume":"15","author":"Abubakar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.crphar.2024.100183_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1515\/med-2019-0093","article-title":"Potential drug-drug interactions in acute ischemic stroke patients at the neurological intensive care unit","volume":"14","author":"Aleksic","year":"2019","journal-title":"Open Med."},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000029","article-title":"Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient","volume":"6","author":"Amariglio","year":"2009","journal-title":"PLoS Med."},{"issue":"Pt 6","key":"10.1016\/j.crphar.2024.100183_bib4","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/brain\/awr094","article-title":"Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain","volume":"134","author":"Andres","year":"2011","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.crphar.2024.100183_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nm747","article-title":"Neuronal replacement from endogenous precursors in the adult brain after stroke","volume":"8","author":"Arvidsson","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.crphar.2024.100183_bib6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1474-4422(22)00117-X","article-title":"Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in The Netherlands (PASSIoN): a first-in-human, open-label intervention study","volume":"21","author":"Baak","year":"2022","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.crphar.2024.100183_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2007.06.012","article-title":"Neural stem\/precursor cells for the treatment of ischemic stroke","volume":"265","author":"Bacigaluppi","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.crphar.2024.100183_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1634\/theoncologist.2-3-196","article-title":"Stem cell-based gene therapy","volume":"2","author":"Bagnis","year":"1997","journal-title":"Oncol."},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/dbio.1995.1085","article-title":"Embryonic stem cells express neuronal properties in vitro","volume":"168","author":"Bain","year":"1995","journal-title":"Dev. Biol."},{"issue":"7","key":"10.1016\/j.crphar.2024.100183_bib10","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.121.036545","article-title":"Circulating extracellular vesicles in stroke patients treated with mesenchymal stem cells: a biomarker analysis of a randomized trial","volume":"53","author":"Bang","year":"2022","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.crphar.2024.100183_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40256-013-0007-6","article-title":"Drug treatment of acute ischemic stroke","volume":"13","author":"Bansal","year":"2013","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"5","key":"10.1016\/j.crphar.2024.100183_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/15321819.2021.1906270","article-title":"Oxytocin improves ischemic stroke by reducing expression of excitatory amino acid transporter 3 in rat MCAO model","volume":"42","author":"Barahimi","year":"2021","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.crphar.2024.100183_bib14","first-page":"Cd005207","article-title":"Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke","volume":"3","author":"Bath","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/cbin.11237","article-title":"Heat shock protein 27 as a neuroprotective biomarker and a suitable target for stem cell therapy and pharmacotherapy in ischemic stroke","volume":"44","author":"Behdarvandy","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.crphar.2024.100183_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","article-title":"Stroke risk factors, genetics, and prevention","volume":"120","author":"Boehme","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.crphar.2024.100183_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/1179573517693802","article-title":"Role of transporters in central nervous system drug delivery and blood-brain barrier protection: relevance to treatment of stroke","volume":"9","author":"Brzica","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcp.21200","article-title":"Adult mesenchymal stem cells for tissue engineering versus regenerative medicine","volume":"213","author":"Caplan","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.crphar.2024.100183_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.RES.0000063425.51108.8D","article-title":"Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats","volume":"92","author":"Chen","year":"2003","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.crphar.2024.100183_bib22","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/scd.2009.0452","article-title":"Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue","volume":"19","author":"Chen","year":"2010","journal-title":"Stem Cells Dev"},{"issue":"7","key":"10.1016\/j.crphar.2024.100183_bib23","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","article-title":"Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke","volume":"96","author":"Chung","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001644","article-title":"Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model","volume":"3","author":"Daadi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.crphar.2024.100183_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221083863","article-title":"Final results of allogeneic adipose tissue-derived mesenchymal stem cells in acute ischemic stroke (AMASCIS): a phase II, randomized, double-blind, placebo-controlled, single-center, pilot clinical trial","volume":"31","author":"de Celis-Ruiz","year":"2022","journal-title":"Cell Transplant."},{"issue":"9","key":"10.1016\/j.crphar.2024.100183_bib26","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/jcbfm.2013.91","article-title":"Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke","volume":"33","author":"Eckert","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"10.1016\/j.crphar.2024.100183_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.WCB.0000071886.63724.FB","article-title":"Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke","volume":"23","author":"Erd\u00f6","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1 Suppl. 1","key":"10.1016\/j.crphar.2024.100183_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbmt.2007.10.022","article-title":"T cell therapy in allogeneic stem cell transplantation","volume":"14","author":"Falkenburg","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.crphar.2024.100183_bib29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","article-title":"Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the TRIDENT study)","volume":"121","author":"Florea","year":"2017","journal-title":"Circ. Res."},{"issue":"5457","key":"10.1016\/j.crphar.2024.100183_bib30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","article-title":"Mammalian neural stem cells","volume":"287","author":"Gage","year":"2000","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.crphar.2024.100183_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/ptj\/84.10.973","article-title":"Pharmacologic management of spasticity following stroke","volume":"84","author":"Gallichio","year":"2004","journal-title":"Phys. Ther."},{"issue":"3","key":"10.1016\/j.crphar.2024.100183_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/2229-3485.83228","article-title":"Regulations and guidelines governing stem cell based products: clinical considerations","volume":"2","author":"George","year":"2011","journal-title":"Perspect Clin Res"},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.expneurol.2006.03.002","article-title":"Pharmacologic management of ischemic stroke: relevance to stem cell therapy","volume":"199","author":"Gilman","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.crphar.2024.100183_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/468748","article-title":"Stem cell-based therapies for ischemic stroke","volume":"2014","author":"Hao","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.crphar.2024.100183_bib35","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1586\/14737175.8.8.1193","article-title":"Cell-based therapy in ischemic stroke","volume":"8","author":"Hess","year":"2008","journal-title":"Expert Rev. Neurother."},{"issue":"5","key":"10.1016\/j.crphar.2024.100183_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01376517-200710000-00005","article-title":"Acute ischemic stroke review","volume":"39","author":"Hinkle","year":"2007","journal-title":"J. Neurosci. Nurs."},{"issue":"Suppl. 1","key":"10.1016\/j.crphar.2024.100183_bib37","doi-asserted-by":"crossref","first-page":"50s","DOI":"10.1016\/S0248-8663(00)88725-1","article-title":"[Digestive complications of aspirin]","volume":"21","author":"Hochain","year":"2000","journal-title":"Rev. Med. Interne"},{"issue":"5","key":"10.1016\/j.crphar.2024.100183_bib38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jnr.21572","article-title":"Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms","volume":"86","author":"Hokari","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.crphar.2024.100183_bib39","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s12975-020-00787-z","article-title":"Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial","volume":"11","author":"Jaillard","year":"2020","journal-title":"Transl Stroke Res"},{"issue":"1\u20132","key":"10.1016\/j.crphar.2024.100183_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11010-011-0806-5","article-title":"Induction of pluripotent stem cells transplantation therapy for ischemic stroke","volume":"354","author":"Jiang","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.crphar.2024.100183_bib41","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3727\/096368912X658818","article-title":"Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery","volume":"22","author":"Jiang","year":"2013","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.crphar.2024.100183_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.291","article-title":"Application of stem cells in regeneration medicine","volume":"4","author":"Jin","year":"2023","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.crphar.2024.100183_bib43","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/jcbfm.2010.32","article-title":"Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain","volume":"30","author":"Kawai","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.crphar.2024.100183_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnen\/nlac011","article-title":"Calcitriol pretreatment attenuates glutamate neurotoxicity by regulating NMDAR and CYP46A1 gene expression in rats subjected to transient middle cerebral artery occlusion","volume":"81","author":"Khassafi","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"13","key":"10.1016\/j.crphar.2024.100183_bib45","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.0b013e3181b9c847","article-title":"Good clinical outcome after ischemic stroke with successful revascularization is time-dependent","volume":"73","author":"Khatri","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.crphar.2024.100183_bib46","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40263-014-0199-6","article-title":"Clinical trials in acute ischemic stroke","volume":"28","author":"Kikuchi","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.crphar.2024.100183_bib47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1745-6215-14-317","article-title":"Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial","volume":"14","author":"Kim","year":"2013","journal-title":"Trials"},{"issue":"20","key":"10.1016\/j.crphar.2024.100183_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207609","article-title":"Pathophysiology and treatment of stroke: present status and future perspectives","volume":"21","author":"Kuriakose","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carrev.2010.01.001","article-title":"Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study","volume":"12","author":"Lasala","year":"2011","journal-title":"Cardiovasc Revasc Med"},{"issue":"9","key":"10.1016\/j.crphar.2024.100183_bib50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jcyt.2021.03.005","article-title":"The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy","volume":"23","author":"Law","year":"2021","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000156","article-title":"Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model","volume":"2","author":"Lee","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/STROKEAHA.121.034505","article-title":"Efficacy of intravenous mesenchymal stem cells for motor recovery after ischemic stroke: a neuroimaging study","volume":"53","author":"Lee","year":"2022","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.crphar.2024.100183_bib54","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cell."},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00006123-200208000-00007","article-title":"Transradial cerebral angiography: an alternative route","volume":"51","author":"Levy","year":"2002","journal-title":"Neurosurgery"},{"issue":"10","key":"10.1016\/j.crphar.2024.100183_bib56","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awl207","article-title":"Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia","volume":"129","author":"Liu","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.crphar.2024.100183_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pneurobio.2013.11.007","article-title":"Cell based therapies for ischemic stroke: from basic science to bedside","volume":"115","author":"Liu","year":"2014","journal-title":"Prog Neurobiol"},{"issue":"7","key":"10.1016\/j.crphar.2024.100183_bib58","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/jcbfm.2010.8","article-title":"Bone marrow stromal cells enhance inter- and intracortical axonal connections after ischemic stroke in adult rats","volume":"30","author":"Liu","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib59","first-page":"10","article-title":"Outpatient service and community health centers","volume":"4","author":"Louria","year":"1969","journal-title":"Bull N J Coll Med Dent"},{"key":"10.1016\/j.crphar.2024.100183_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6940283","article-title":"Stem cells applications in regenerative medicine and disease therapeutics","volume":"2016","author":"Mahla","year":"2016","journal-title":"Int J Cell Biol"},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020695","article-title":"Drug delivery systems in regenerative medicine: an updated review","volume":"15","author":"Mansour","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.crphar.2024.100183_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fneur.2018.00034","article-title":"Potential of stem cell-based therapy for ischemic stroke","volume":"9","author":"Marei","year":"2018","journal-title":"Front. Neurol."},{"issue":"13 Suppl. 1","key":"10.1016\/j.crphar.2024.100183_bib63","first-page":"S207","article-title":"Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy","volume":"79","author":"Misra","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.crphar.2024.100183_bib64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biomaterials.2016.07.028","article-title":"Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain","volume":"105","author":"Moshayedi","year":"2016","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.crphar.2024.100183_bib65","first-page":"701","article-title":"Lipoprotein lipase gene polymorphisms as risk factors for stroke: a computational and meta-analysis","volume":"21","author":"Nejati","year":"2018","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2004.11.055","article-title":"Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations","volume":"1035","author":"Neuhuber","year":"2005","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2005.06.062","article-title":"I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat","volume":"136","author":"Nomura","year":"2005","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.crphar.2024.100183_bib68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.drudis.2020.01.007","article-title":"Novel approaches for the delivery of therapeutics in ischemic stroke","volume":"25","author":"Nozohouri","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib69","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.jcbfm.9600527","article-title":"Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia","volume":"28","author":"Onda","year":"2008","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.crphar.2024.100183_bib70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1479-5876-6-54","article-title":"Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice","volume":"6","author":"Oyamada","year":"2008","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.crphar.2024.100183_bib71","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ejhf.1412","article-title":"Rationale and design of the European multicentre study on stem cell therapy in IschEmic non-treatable cardiac diseasE (SCIENCE)","volume":"21","author":"Paitazoglou","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1254\/jjp.87.97","article-title":"Brain drug targeting and gene technologies","volume":"87","author":"Pardridge","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.crphar.2024.100183_bib73","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.0903143","article-title":"Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta","volume":"184","author":"Patel","year":"2010","journal-title":"J. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.crphar.2024.100183_bib74","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.3727\/096368914X684961","article-title":"A two-year follow-up study of cotransplantation with neural stem\/progenitor cells and mesenchymal stromal cells in ischemic stroke patients","volume":"23","author":"Qiao","year":"2014","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.crphar.2024.100183_bib75","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/74447","article-title":"Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro","volume":"18","author":"Reubinoff","year":"2000","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcb.21172","article-title":"Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2","volume":"101","author":"Ringe","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"18","key":"10.1016\/j.crphar.2024.100183_bib77","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/CIRCULATIONAHA.106.641670","article-title":"Are stem cells drugs? The regulation of stem cell research and development","volume":"114","author":"Rosen","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.crphar.2024.100183_bib78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1741-7007-9-42","article-title":"Stem cell biology and drug discovery","volume":"9","author":"Rubin","year":"2011","journal-title":"BMC Biol."},{"issue":"2","key":"10.1016\/j.crphar.2024.100183_bib79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/stemcells.2006-0380","article-title":"Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin","volume":"25","author":"Sonntag","year":"2007","journal-title":"Stem Cell."},{"issue":"3","key":"10.1016\/j.crphar.2024.100183_bib80","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00018-018-2953-2","article-title":"The regulatory role of Toll-like receptors after ischemic stroke: neurosteroids as TLR modulators with the focus on TLR2\/4","volume":"76","author":"Tajalli-Nezhad","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.crphar.2024.100183_bib81","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.crphar.2024.100183_bib82","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.041","article-title":"Role of steroid therapy after ischemic stroke by n-Methyl-d-Aspartate receptor gene regulation","volume":"27","author":"Tameh","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.crphar.2024.100183_bib83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3727\/096368910X491374","article-title":"The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells","volume":"19","author":"Tat","year":"2010","journal-title":"Cell Transplant."},{"issue":"3","key":"10.1016\/j.crphar.2024.100183_bib84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18773\/austprescr.2021.018","article-title":"Drugs in secondary stroke prevention","volume":"44","author":"Tremonti","year":"2021","journal-title":"Aust. Prescr."},{"issue":"9","key":"10.1016\/j.crphar.2024.100183_bib85","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1007\/s12035-021-02435-5","article-title":"G-Protein-Coupled receptors and ischemic stroke: a focus on molecular function and therapeutic potential","volume":"58","author":"Vahidinia","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.crphar.2024.100183_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105163","article-title":"Neurosteroids and their receptors in ischemic stroke: from molecular mechanisms to therapeutic opportunities","volume":"160","author":"Vahidinia","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.crphar.2024.100183_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106331","article-title":"Calcitriol ameliorates brain injury in the rat model of cerebral ischemia-reperfusion through Nrf2\/HO-1 signalling Axis: an in silico and in vivo study","volume":"31","author":"Vahidinia","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.crphar.2024.100183_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7603\/s40730-016-0047-z","article-title":"Stem cell drugs: the next generation of pharmaceutical products","volume":"3","author":"Van Pham","year":"2016","journal-title":"Biomedical Research and Therapy"},{"issue":"9","key":"10.1016\/j.crphar.2024.100183_bib89","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/cells11091553","article-title":"Insight into the role of the PI3K\/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart","volume":"11","author":"Walkowski","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.crphar.2024.100183_bib90","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1177\/0963689718795424","article-title":"Transplanting mesenchymal stem cells for treatment of ischemic stroke","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Transplant."},{"key":"10.1016\/j.crphar.2024.100183_bib91","article-title":"Enhancing regenerative medicine: the crucial role of stem cell therapy","volume":"18","author":"Wang","year":"2024","journal-title":"Front. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.crphar.2024.100183_bib92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2004.12.016","article-title":"Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia","volume":"19","author":"Wei","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.crphar.2024.100183_bib93","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2017.03.003","article-title":"Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke","volume":"157","author":"Wei","year":"2017","journal-title":"Prog Neurobiol"},{"issue":"10","key":"10.1016\/j.crphar.2024.100183_bib94","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.mayocp.2012.04.017","article-title":"Ten common questions (and their answers) about off-label drug use","volume":"87","author":"Wittich","year":"2012","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.crphar.2024.100183_bib95","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3727\/096368910X539092","article-title":"Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain","volume":"20","author":"Yamashita","year":"2011","journal-title":"Cell Transplant."},{"issue":"24","key":"10.1016\/j.crphar.2024.100183_bib96","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0149-06.2006","article-title":"Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum","volume":"26","author":"Yamashita","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.crphar.2024.100183_bib97","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2006.08.007","article-title":"Improvement of focal ischemia-induced rat dopaminergic dysfunction by striatal transplantation of mouse embryonic stem cells","volume":"407","author":"Yanagisawa","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.crphar.2024.100183_bib98","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)81437-3","article-title":"FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate","volume":"93","author":"Ye","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.crphar.2024.100183_bib99","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2934149","article-title":"Stem cell tracking technologies for neurological regenerative medicine purposes","volume":"2017","author":"Zheng","year":"2017","journal-title":"Stem Cells Int"},{"issue":"3","key":"10.1016\/j.crphar.2024.100183_bib100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10753-019-00960-z","article-title":"Umbilical cord blood mesenchymal stem cells enhance lipopolysaccharide-induced IL-10 and IL-37 production in THP-1 cells","volume":"42","author":"Zhou","year":"2019","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.crphar.2024.100183_bib101","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/aps.2018.23","article-title":"Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults","volume":"39","author":"Zhu","year":"2018","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257124000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257124000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T18:46:56Z","timestamp":1718563616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590257124000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":101,"alternative-id":["S2590257124000105"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2024.100183","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell therapy as a promising approach for ischemic stroke treatment","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2024.100183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100183"}}